Ergoteles LLC Black Diamond Therapeutics, Inc. Transaction History

Ergoteles LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.43 - $6.18 $143,000 - $618,000	100,000 New	100,000 $505,000
Q4 2022 Feb 14, 2023	SELL	$1.27 - $2.51 $38,271 - $75,638	-30,135 Reduced 59.85%	20,212 $36,000
Q3 2022 Nov 14, 2022	SELL	$1.68 - $4.01 $100,217 - $239,208	-59,653 Reduced 54.23%	50,347 $85,000
Q2 2022 Aug 12, 2022	BUY	$1.5 - $3.63 $165,000 - $399,300	110,000 New	110,000 $271,000
Q4 2021 Feb 14, 2022	SELL	$5.18 - $8.48 $116,197 - $190,223	-22,432 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$8.46 - $12.42 $189,774 - $278,605	22,432 New	22,432 $190,000

118

48.8M

1.84M

1.93M

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $99.2M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.